| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |